Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00662142 · ClinicalTrials.gov registry record · Phase 3
Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function
A Phase 3 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT00662142 is a Phase 3 study that has completed, run by University of Cincinnati. The registered enrollment target is 30 participants.
The verdict
NCT00662142, a Phase 3 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this study is to determine if 8-week dietary treatment with the omega-3 fatty acid docosahexaenoic acid (DHA) improves attention performance and associated cortical activity and metabolism in 8 - 10 year old males that were not breast-fed during infancy.
Interventions
- DIETARY_SUPPLEMENT docosahexaenoic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00662142
The ClinicalTrials.gov registry entry for NCT00662142 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which docosahexaenoic acid is the first listed.
NCT00662142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00662142 about?
NCT00662142 is a clinical study titled "Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function". The goal of this study is to determine if 8-week dietary treatment with the omega-3 fatty acid docosahexaenoic acid (DHA) improves attention performance and associated cortical activity and metabolism in 8 - 10 year old males that were not breast-fed during infancy.
What is the current status of trial NCT00662142?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2006-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00662142?
The interventions under investigation include: docosahexaenoic acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00662142?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.